Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00208117 · ClinicalTrials.gov registry record · Phase 1
A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease
A Phase 1 study, sponsored by New York State Psychiatric Institute.
- Terminated
- Registry status
- Phase 1
- Development phase
- 7
- Enrollment target
NCT00208117 is a Phase 1 study that was terminated before completion, run by New York State Psychiatric Institute. The registered enrollment target is 7 participants.
The verdict
NCT00208117, a Phase 1 study, was terminated before completion, sponsored by New York State Psychiatric Institute.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 7 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the relationship between depressive symptoms and markers of inflammation, two predictors of heart disease.
Interventions
- DRUG Sertraline (Zoloft)
- DRUG Simvastatin (Zocor)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2005-04 |
| Est. Completion | 2009-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00208117
The ClinicalTrials.gov registry entry for NCT00208117 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 7 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York State Psychiatric Institute, which has 364 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Sertraline (Zoloft) is the first listed.
NCT00208117 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00208117 about?
NCT00208117 is a clinical study titled "A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease". The purpose of this study is to examine the relationship between depressive symptoms and markers of inflammation, two predictors of heart disease.
What is the current status of trial NCT00208117?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 7 participants. The study started on 2005-04. Estimated completion is 2009-01.
What interventions are being tested in trial NCT00208117?
The interventions under investigation include: Sertraline (Zoloft) (DRUG), Simvastatin (Zocor) (DRUG).
Who is sponsoring clinical trial NCT00208117?
This trial is sponsored by New York State Psychiatric Institute, which has 364 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.